Publication
Is serotonin receptor HTR1B implicated in mesial temporal lobe epilepsy development?
| dc.contributor.author | Leal, B. | |
| dc.contributor.author | Barreira, A. | |
| dc.contributor.author | Chaves, J. | |
| dc.contributor.author | Carvalho, C. | |
| dc.contributor.author | Bettencourt, A. | |
| dc.contributor.author | Martins da Silva, A. | |
| dc.contributor.author | Costa, P.P. | |
| dc.contributor.author | Martins da Silva, B. | |
| dc.date.accessioned | 2014-04-03T10:35:05Z | |
| dc.date.available | 2014-04-03T10:35:05Z | |
| dc.date.issued | 2013-09-22 | |
| dc.description.abstract | Background: Evidences from animal models have demonstrated that depletion of brain serotonin (5-HT), a neurotransmitter with a pivotal role in neurodevelopment and brain plasticity, lowers the threshold to induced seizures. It was also demonstrated that anti-epileptic drugs increase endogenous 5-HT concentrations and that 5HT-1B receptors could have an anticonvulsant role. Association studies have demonstrated that a polymorphism (rs6296) in 5HTR-1B gene may be a susceptibility factor for with temporal lobe epilepsy (TLE) development. The rs6296 G allele has been associated with decreased receptor activity. Our aim was to analyse the association between rs6296 and the development and clinical features of Mesial Temporal Lobe Epilepsy (MTLE) in a Portuguese population. Material and methods: A cohort of 121 MTLE patients (67 F, 54 M, mean age = 44 ± 11 years, age of onset = 13 ± 9 years) was compared with a cohort of 192 healthy individuals (HI). All patients had Hippocampal Sclerosis (MTLE–HS). Genotyping was performed by TaqMan real time PCR methodology. Results: rs6296 G allele was overrepresented in MTLE patients compared to controls (80.2% in MTLE vs 72.1% in HI, p = 0.029 OR = 1.561 (1.060–2.298)). We constituted 2 MTLE–HS sub-groups, according to febrile seizure antecedents and no differences in rs6596 allelic or genotypic frequencies were found. Conclusion: The rs6296 G allele may be a susceptibility factor to MTLE–HS development. Since these receptors have an anticonvulsant role, a reduction in their activity could lower the threshold for seizure development. | por |
| dc.description.sponsorship | Supported by a BICE Tecnifar Grant 2012 | por |
| dc.identifier.citation | J Neurol Sci. 2013;133(S1):e41 | por |
| dc.identifier.issn | 0022-510X | |
| dc.identifier.uri | http://hdl.handle.net/10400.18/2216 | |
| dc.language.iso | eng | por |
| dc.peerreviewed | no | por |
| dc.publisher | Elsevier/ World Federation of Neurology | por |
| dc.relation.publisherversion | http://www.sciencedirect.com/science/article/pii/S0022510X13004607 | |
| dc.subject | Epilepsy | por |
| dc.subject | MTLE | por |
| dc.subject | Serotonin | por |
| dc.subject | HTR1B | por |
| dc.subject | Genetic Association | por |
| dc.subject | Complex Disease Genetics | por |
| dc.subject | Determinantes da Saúde e da Doença | por |
| dc.subject | Doenças Genéticas | por |
| dc.title | Is serotonin receptor HTR1B implicated in mesial temporal lobe epilepsy development? | por |
| dc.type | conference object | |
| dspace.entity.type | Publication | |
| oaire.citation.conferencePlace | Vienna, Austria | por |
| oaire.citation.endPage | e41 | por |
| oaire.citation.startPage | e41 | por |
| oaire.citation.title | XXI World Congress of Neurology, 21-26 September 2013 | por |
| oaire.citation.volume | 333(S1) | por |
| rcaap.rights | embargoedAccess | por |
| rcaap.type | conferenceObject | por |
